Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

OBJECTIVES: The benefit of adjuvant chemotherapy in patients with localized uterine leiomyosarcoma (LMS) remains unclear due to a lack of randomized studies and data only from small retrospective series to rely on. We sought to identify factors associated with the administration of chemotherapy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Dhara, Handorf, Elizabeth, von Mehren, Margaret, Martin, Lainie, Movva, Sujana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387708/
https://www.ncbi.nlm.nih.gov/pubmed/30881199
http://dx.doi.org/10.1155/2019/3561501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387708/
https://www.ncbi.nlm.nih.gov/pubmed/30881199
http://dx.doi.org/10.1155/2019/3561501

Ejemplares similares